Can We Harness Immune Responses to Improve Drug Treatment in Leishmaniasis?

Leishmaniasis is a vector-borne parasitic disease that has been neglected in priority for control and eradication of malaria, tuberculosis, and HIV/AIDS. Collectively, over one seventh of the world’s population is at risk of being infected with 0.7–1.2 million new infections reported annually. Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Aruleba, Raphael Taiwo, Carter, Katharine C., Brombacher, Frank, Hurdayal, Ramona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409143/
https://www.ncbi.nlm.nih.gov/pubmed/32709117
http://dx.doi.org/10.3390/microorganisms8071069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409143/
https://www.ncbi.nlm.nih.gov/pubmed/32709117
http://dx.doi.org/10.3390/microorganisms8071069

Ejemplares similares